161 - Vaccine Challenging Cases

Interactive Moderator(s)

• 

  Kathryn Edwards, MD

  Professor of Pediatrics
  Vanderbilt University Medical Center
  Nashville, TN, United States

  Disclosure(s): Bionet: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Data Monitoring Committee (Ongoing); Merck & Co. Inc: Data Monitoring Committee (Ongoing); Moderna, Inc.: Data Monitoring Committee (Ongoing); Pfizer, Inc.: Data Monitoring Committee (Ongoing); Roche Inc: Data Monitoring Committee (Ongoing); Sanofi Pasteur Inc.: Data Monitoring Committee (Ongoing); Seqirus Vaccine Ltd.: Data Monitoring Committee (Ongoing); X-4 Pharma: Adjudication Committee (Ongoing)

  Slides
• KT

  Kawsar Talaat, MD (she/her/hers)

  Associate Professor
  Johns Hopkins Bloomberg School of Public Health
  Baltimore, MD, United States

  Disclosure(s): Intralytix: Scientific Advisory Board (Ongoing); Merck and Company, Inc.: Data and Safety Monitoring Board (Ongoing); Pfizer, Inc.: Grant/Research Support (Ongoing); Sanofi Pasteur Inc.: Grant/Research Support (Ongoing); Takeda Vaccines: Data and Safety Monitoring Board (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P